The end of drug shortages are usually good news, but for patients on tirzepatide, it brings fear because their accustomed medications may become less accessible.
Gianna Green describes her experience with tirzepatide as "absolutely devastating" as she fears losing access to a drug she finds "completely life-changing." Long-term users are worried about supply issues.
Pharmacies can produce compounded versions of drugs during shortages. These custom substitutes are not FDA-approved, which raises concerns, despite meeting the immediate needs of patients.
The surge in demand for GLP-1 medications has led to the rise of compounded tirzepatide and semaglutide, which telehealth companies offer at significantly lower prices.
Collection
[
|
...
]